סינגולייר 4 מ"ג גרנולות לקטנטנים

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

MONTELUKAST AS SODIUM 4 MG

Available from:

MERCK SHARP & DOHME ISRAEL LTD

ATC code:

R03DC03

Pharmaceutical form:

GRANULES

Administration route:

PER OS

Manufactured by:

MERCK SHARP & DOHME, NETHERLANDS

Therapeutic group:

MONTELUKAST

Therapeutic indications:

Singulair is indicated in adult and pediatric patients 12 months of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treament of aspirin - sensitive asthmatic patients, and the prevention of exercise - induced bronchoconstriction. Singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Singulair and inhaled corticosteroids may be used concomitatly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.

Authorization date:

2009-01-01